Background High rates of revision surgery have been reported for laparoscopic sleeve gastrectomy (LSG), with weight regain (WR) as the most frequently reported cause. Roux-en-Y gastric bypass (RYGB) is the most commonly performed revision procedure, whereas one-anastomosis gastric bypass (OAGB) is a less popular approach. Methods A single-blinded randomized controlled trial was conducted. One hundred seventy-six patients were enrolled and randomized. After loss to follow-up, 80 patients for RYGB and 80 patients for OAGB were analyzed, with a 2-year follow-up. Patients with grade B or higher gastroesophageal reflux disease (GERD) were excluded. Early and late postoperative complications were recorded. Body mass index (BMI), percentage of excess BMI loss (%EBMIL), nutritional laboratory test results, and the resolution of associated medical problems were assessed after revision surgery. Results After 2 years, both groups achieved significantly lower BMI than their post-LSG nadir BMI (p < 0.001). The %EBMIL changes showed significantly faster weight loss in the OAGB group than in the RYGB at the 6-month follow-up (mean difference: 8.5%, 95% confidence interval [CI]: 0.2 to 16.9%). However, at 1-year and 2-year follow-ups, the differences were statistically insignificant (p > 0.05). Early and late complications were similar between two groups. Both groups showed improvement or resolution of associated medical problems, with no statistically significant differences after 2 years (p = 1.00). Conclusion Both revisional RYGB and OAGB have comparable significant weight loss effects when performed for WR after LSG. After a 2-year follow-up, both procedures were safe, with no significant differences in the occurrence of complications and nutritional deficits. Graphical abstract
Background: Egypt joined several countries in immunizing her citizens with COVID19 vaccines; a priority was given to health care workers (HCWs), then to patients with chronic diseases. However, HCWs are exposed to a higher viral load; in addition, asymptomatic infection is commoner among them, thus potentially exposing them to a more severe illness. Objective(s):To identify the determinants of the severity of COVID-19 infection among HCWs. Methods: A case control study was conducted, where we recruited HCWs diagnosed as moderate or severe COVID-19 from isolation and critical care units; and compared their vaccination exposure with that among matched controls. A data collection sheet was filled by residents and included information about mask wearing, comorbidities, smoking, and COVID-19 manifestations. Results:The predictors that significantly affected severity of infection were cardiovascular or cerebrovascular diseases, being a nurse, and mask compliance (OR 17.38 p=0.012 *, OR 5.86, p=0.002*, and OR=0.06, p=0.001 *respectively). Most females, as well as nurses were not vaccinated (90% p= 0.009 *, and 83.3% p=0.016 *respectively). There was no significant difference in mean oxygen saturation between vaccinated and non-vaccinated cases. Conclusion: Among HCWs, the most significantly protective factor against COVID-19 moderate and severe illness was mask compliance. Furthermore, being a nurse as well as having cardiovascular or cerebrovascular disease were significant positive predictors of getting a more severe disease. There was no significant effect of vaccination on severity of COVID19 illness.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.